Promising start-up opts for Ypsomed's user-friendly autoinjector to treat PMDD
Asarina Pharma has decided to go with our user-friendly two-step autoinjector YpsoMate for its commercial launch of its drug Sepranolone. Sepranolone is the world’s first treatment for pre-menstrual dysphoric disorder (PMDD).
Ultra-modern production plant for injection and infusion systems has started well
At the end of August, we ceremoniously opened our new state-of-the-art production plant in Schwerin, in North-East Germany. The production got off to a good start. Today, three months later, a perfectly tuned team is at work.
YpsoDose is a patch injector for large volumes. When developing YpsoDose, we focus on user-friendliness as we do with all our injection systems. The latest user studies have confirmed how easy YpsoDose is to use.
November 14 is a day of great importance for Ypsomed. Today is World Diabetes Day as well as National Future Day in Switzerland, where our headquarters are located. Today, we have the opportunity to draw attention to diabetes and to equality.